[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100479923":3},{"organization":4,"armGroups":7,"interventions":29,"overallOfficials":45,"centralContacts":34,"locations":50,"responsibleParty":62,"collaborators":34,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":34,"eligibilityCriteria":71,"healthyVolunteers":72,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":34,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":34,"overallStatus":85,"whyStopped":34,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Yuzuncu Yil University","OTHER",[8,14,19,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexketoprofen Trometamol + Thiocolchicoside","ACTIVE_COMPARATOR","(25mg + 4mg, 2x1)",[13],"Drug: Dexketoprofen Trometamol + Thiocolchicoside",{"label":15,"type":10,"description":16,"interventionNames":17},"Dexketoprofen Trometamol + Paracetamol","(25mg + 300mg, 2x1)",[18],"Drug: Dexketoprofen Trometamol + Paracetamol",{"label":20,"type":10,"description":21,"interventionNames":22},"Dexketoprofen Trometamol","(25mg, 2x1)",[23],"Drug: Dexketoprofen Trometamol (25mg)",{"label":25,"type":10,"description":26,"interventionNames":27},"Paracetamol","(500 mg, 4x1)",[28],"Drug: Paracetamol",[30,35,38,42],{"type":31,"name":9,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","Dexketoprofen Trometamol + Thiocolchicoside (25mg + 4mg) is a NSAID. It was given to the patients twice a day.",[9],null,{"type":31,"name":15,"description":36,"armGroupLabels":37,"otherNames":34},"Dexketoprofen Trometamol + Paracetamol (25mg + 300mg) is a NSAID. It was given to the patients twice a day.",[15],{"type":31,"name":39,"description":40,"armGroupLabels":41,"otherNames":34},"Dexketoprofen Trometamol (25mg)","Dexketoprofen Trometamol (25mg) is a NSAID. It was given to the patients twice a day.",[20],{"type":31,"name":25,"description":43,"armGroupLabels":44,"otherNames":34},"Paracetamol (500 mg) is a mild analgesic and antipyretic. It was given to the patients to take only if needed as max. dose 2000mg.",[25],[46],{"name":47,"affiliation":48,"role":49},"Levent Ciğerim, Assoc.Prof.","Van Yuzuncu Yil University, Faculty of Dentistry","STUDY_DIRECTOR",[51],{"facility":48,"status":34,"city":52,"state":53,"zip":54,"country":55,"countryCode":34,"cosmosGeoPoint":56,"geoPoint":61,"contacts":34},"Van","Tuşba","65080","Turkey (Türkiye)",{"type":57,"coordinates":58},"Point",[59,60],43.38323,38.49457,{"lat":60,"lon":59},{"type":63,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"PRINCIPAL_INVESTIGATOR","levent Cigerim","Head of Oral and Maxillofacial Surgery Department","100479923","phase-4-evaluation-of-the-efficacy-of-different-drugs-in-the-treatment-of-the-pain-in-patients-with-temporomandibular-disorder-100479923",false,"NCT05529290","Evaluation of the Efficacy of Different Drugs in the Treatment of the Pain in Patients With Temporomandibular Disorder","Inclusion Criteria:\n\n1. Individuals aged 18 and over\n2. Individuals without any systemic disease\n3. Individuals without missing teeth\n4. Individuals who have not used any medication in the last week\n5. Individuals with normal TMJ MR imaging\n6. Patients who applied to our clinic and had pain due to temporomandibular disease.\n\nExclusion Criteria:\n\n1. Individuals who do not come to their check-ups regularly\n2. Individuals allergic to any of the study drugs\n3. Pregnant and lactating individuals",true,"ALL","18 Years","40 Years",{"count":77,"type":78},200,"ACTUAL","INTERVENTIONAL",[81],"PHASE4","The most important step in the treatment of TMJ (temporomandibular joint) disease in clinical dentistry is diagnosis and planning. The clinical findings, drug requirement and biological risk of the patients determine the examination methods to be used in the Treatment of Temporomandibular Joint Disorders. In this context, it is thought that studies in the field of dentistry should be increased in order to increase the success in the treatment of TMJ Disorders. The aim of the study is to evaluate the efficacy of of different pain relievers as Dexketoprofen Trometamol + Thiocolchicoside, dexketoprofen trometamol + paracetamol and Dexketoprofen Trometamol in the treatment of pain in TMJ disorders.",[84],"Temporomandibular Disorder","COMPLETED","2023-08-20",{"date":88,"type":78},"2023-08-22",{"date":90,"type":78},"2019-07-16",{"date":92,"type":78},"2022-02-01",{"name":5,"class":6},1]